Results 61 to 70 of about 33,349 (194)

Investigating the knowledge and attitude of mothers with teenagers toward human papillomavirus vaccine injection

Journal of Education and Health Promotion
BACKGROUND: Human papillomavirus (HPV) is a large family of viruses and is considered the most common sexually transmitted infection. One of the effective and cost-effective primary prevention methods are vaccines made against the HPV.
Leila Shasti, Sayeda Zeinab Hoseinnezhad, Zohre Keshavarz, Maryam Najiabhary, Farangis Habibi, Zeinab Hamzegardeshi   +5 more
doaj   +1 more source

Women's experiences, responses, and coping strategies when testing positive for human papillomavirus in cervical cancer screening: A qualitative study

Acta Obstetricia et Gynecologica Scandinavica, EarlyView.
This study demonstrates that women's experiences following an hrHPV diagnosis within cervical screening extend beyond individual reactions to medical information, encompassing complex psychological, social, and cultural dimensions that influence how women interpret and manage the diagnosis.
Joan Hansen, Beth J. Maclin, Birgitte Folmann, Jane Ege Møller, Ane Kersti Skaarup Knudsen, Vibeke Raaby, Anne Hammer   +6 more
wiley   +1 more source

Rationale for Recommending Varicella Vaccination Into the Swedish National Immunisation Programme

Acta Paediatrica, EarlyView.
ABSTRACT Aim Under Swedish law, a vaccination may be included in the National Immunisation Programme (NIP) if it effectively prevents transmission in the population, is cost‐effective and aligns with ethical and humanitarian principles. The Public Health Agency of Sweden (PHAS) evaluated these criteria for introducing varicella vaccination. Methods The
Annika Ersson, Kari Johansen, Sören Andersson   +2 more
wiley   +1 more source

HPV vaccination of immunocompromised hosts

Papillomavirus Research, 2017
It is well-established that immunocompromised people are at increased risk of HPV-related disease compared with those who are immunocompetent. Prophylactic HPV sub-unit vaccines are safe and immunogenic in immunocompromised people and it is strongly ...
S.M. Garland, J.M.L. Brotherton, A.B. Moscicki, A.M. Kaufmann, M. Stanley, N. Bhatla, R. Sankaranarayanan, S. de Sanjosé, J.M. Palefsky   +8 more
doaj   +1 more source

Therapeutic potential of natural products in cancer immunotherapy: Advances and challenges

British Journal of Pharmacology, EarlyView.
This review systematically outlines the mechanisms underlying tumour immunotherapy resistance and elucidates the role of natural products in enhancing therapeutic efficacy as immunomodulatory adjuvants. Abstract Immunotherapy has emerged as a clinically pivotal approach in cancer treatment, but its application remains limited to a small subset of ...
Rao Hu, Kaibin Dai, Zhensheng Lin, Mingfang Ye, Minfeng Chen, Xiaobo Li, Dongmei Zhang   +6 more
wiley   +1 more source

RNA Extended Interventional Nucleic Acid (REINA) Longitudinal Study: Decreased Risk of CIN2+/CIN3+ With Low‐Grade Cytology After A Previous Negative HPV Test

Cytopathology, EarlyView.
REINA study shows decreased immediate and long‐term risks of CIN2+ and CIN3+ lesions in mRNA HPV‐positive women with minor cytological abnormalities after a previous negative Aptima HPV test in the first round. The decreased CIN2+/CIN3+ risks, below colposcopy referral thresholds, can modify women's management, highlighting the importance of ...
Rosario Granados, Joanny A. Duarte, David R. Luján, Ana M. Gutierrez‐Pecharromán, Isabel Solís, Lourdes Molpeceres, Paloma Bajo   +6 more
wiley   +1 more source

HPV42 – a human papillomavirus classified as a low‐risk type with oncogenic potential

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Human papillomavirus (HPV) type 42 is a rare HPV type currently classified as “low‐risk” and belongs to the alpha genus. It has primarily been detected in benign vulvar papillomas and is predominantly associated with benign lesions such as anogenital warts.
Sven Niklas Burmann, Ulrike Wieland, Steffi Silling, Frank Oellig, David Chromy, Julia Hyun, Thilo Gambichler, Alexander Kreuter   +7 more
wiley   +1 more source

Human papillomavirus and HPV vaccines: a review

Bulletin of the World Health Organization
Cervical cancer, the most common cancer affecting women in developing countries, is caused by persistent infection with "high-risk" genotypes of human papillomaviruses (HPV). The most common oncogenic HPV genotypes are 16 and 18, causing approximately 70%
FT Cutts, S Franceschi, S Goldie, X Castellsague, S de Sanjose, G Garnett, WJ Edmunds, P Claeys, KL Goldenthal, DM Harper, L Markowitz   +10 more
doaj   +1 more source

Achieving Cancer Prevention Equity: A Policy Analysis of American Cancer Society HPV Vaccination Guidelines

Journal of Advanced Nursing, EarlyView.
ABSTRACT Aim To examine the American Cancer Society's HPV vaccination guidelines through a nursing policy analysis framework, assessing justice and equity outcomes in cancer prevention policy implementation. Background Human papillomavirus vaccination remains critical for cancer prevention, yet persistent health disparities undermine equity goals ...
Grace K. Kyei, Evans K. Kyei, Rockson Ansong   +2 more
wiley   +1 more source

Human Papillomavirus (HPV) Vaccines: 13 Years Later

DST
This Editor's Letter, which some may interpret as a manifesto, is about the need to always recognize the progress made by public administrators. However, it is necessary, perhaps fundamental, to demand better public health actions for all population ...
Mauro Passos
doaj   +1 more source